ACOXL and endometrial cancer: In addition, the Cu2+ plus Elesclomol-treated group showed significantly higher gene expression levels for ACOXL-AS1 and hsa-mir-421 (p < 0.01, Figure 8C), while low expression levels were observed for MTF1 gene and protein in two endometrial cancer cell lines (p < 0.01, Figure 8C, 8D).